XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.24.3

DEFERRED ACQUISITION COSTS, PRESENT VALUE OF FUTURE PROFITS AND SALES INDUCEMENTS | 9 Months Ended
--- | ---
Sep. 30, 2024
Deferred Charges, Insurers [Abstract] |
DEFERRED ACQUISITION COSTS, PRESENT VALUE OF FUTURE PROFITS AND SALES INDUCEMENTS | DEFERRED ACQUISITION COSTS, PRESENT VALUE OF FUTURE PROFITS AND SALES INDUCEMENTS Changes in deferred acquisition costs were as follows (dollars in millions):
|  | Nine months ended
|  | September 30, 2024
|  | Fixed indexed annuities |  | Fixed interest annuities |  | Supplemental health |  | Medicare supplement |  | Long-term care |  | Interest-sensitive life |  | Traditional life |  | Funding agreements |  | Total
Beginning of period |  | $ | 407.6 |  |  | $ | 27.0 |  |  | $ | 408.0 |  |  | $ | 157.5 |  |  | $ | 140.3 |  |  | $ | 234.5 |  |  | $ | 471.9 |  |  | $ | 4.5 |  |  | $ | 1,851.3 |
Capitalizations |  | 72.7 |  |  | 9.4 |  |  | 47.2 |  |  | 19.3 |  |  | 16.2 |  |  | 28.0 |  |  | 88.1 |  |  | 5.5 |  |  | 286.4 |
Amortization expense |  | (41.7) |  |  | (3.6) |  |  | (25.7) |  |  | (19.9) |  |  | (11.0) |  |  | (11.6) |  |  | (44.3) |  |  | (1.5) |  |  | (159.3) |
End of period |  | $ | 438.6 |  |  | $ | 32.8 |  |  | $ | 429.5 |  |  | $ | 156.9 |  |  | $ | 145.5 |  |  | $ | 250.9 |  |  | $ | 515.7 |  |  | $ | 8.5 |  |  | $ | 1,978.4 |
|  | Nine months ended
|  | September 30, 2023
|  | Fixed indexed annuities |  | Fixed interest annuities |  | Supplemental health |  | Medicare supplement |  | Long-term care |  | Interest-sensitive life |  | Traditional life |  | Funding agreements |  | Total
Beginning of period |  | $ | 365.6 |  |  | $ | 19.6 |  |  | $ | 378.8 |  |  | $ | 161.2 |  |  | $ | 137.9 |  |  | $ | 212.2 |  |  | $ | 409.1 |  |  | $ | 6.0 |  |  | $ | 1,690.4 |
Capitalizations |  | 65.5 |  |  | 8.0 |  |  | 43.8 |  |  | 17.7 |  |  | 11.3 |  |  | 27.5 |  |  | 86.9 |  |  | — |  |  | 260.7 |
Amortization expense |  | (34.1) |  |  | (2.8) |  |  | (23.2) |  |  | (21.0) |  |  | (11.5) |  |  | (10.7) |  |  | (37.9) |  |  | (1.2) |  |  | (142.4) |
End of period |  | $ | 397.0 |  |  | $ | 24.8 |  |  | $ | 399.4 |  |  | $ | 157.9 |  |  | $ | 137.7 |  |  | $ | 229.0 |  |  | $ | 458.1 |  |  | $ | 4.8 |  |  | $ | 1,808.7 |
Changes in the present value of future profits were as follows (dollars in millions):
|  | Nine months ended
|  | September 30, 2024
|  | Supplemental health |  | Medicare supplement |  | Long-term care |  | Traditional life |  | Fixed indexed annuities |  | Fixed interest annuities |  | Total
Beginning of period |  | $ | 141.0 |  |  | $ | 20.6 |  |  | $ | 5.2 |  |  | $ | 12.9 |  |  | $ | .7 |  |  | $ | .3 |  |  | $ | 180.7 |
Amortization expense |  | (9.3) |  |  | (3.8) |  |  | (.6) |  |  | (1.2) |  |  | (.1) |  |  | — |  |  | (15.0) |
End of period |  | $ | 131.7 |  |  | $ | 16.8 |  |  | $ | 4.6 |  |  | $ | 11.7 |  |  | $ | .6 |  |  | $ | .3 |  |  | $ | 165.7 |
|  | Nine months ended
|  | September 30, 2023
|  | Supplemental health |  | Medicare supplement |  | Long-term care |  | Traditional life |  | Fixed indexed annuities |  | Fixed interest annuities |  | Total
Beginning of period |  | $ | 154.0 |  |  | $ | 27.5 |  |  | $ | 6.2 |  |  | $ | 14.8 |  |  | $ | .8 |  |  | $ | .4 |  |  | $ | 203.7 |
Amortization expense |  | (9.8) |  |  | (5.3) |  |  | (.8) |  |  | (1.4) |  |  | (.1) |  |  | (.1) |  |  | (17.5) |
End of period |  | $ | 144.2 |  |  | $ | 22.2 |  |  | $ | 5.4 |  |  | $ | 13.4 |  |  | $ | .7 |  |  | $ | .3 |  |  | $ | 186.2 |
Changes in sales inducements were as follows (dollars in millions):
|  | Nine months ended
|  | September 30, 2024
|  | Fixed indexed annuities |  | Fixed interest annuities |  | Total
Beginning of period |  | $ | 88.5 |  |  | $ | 4.6 |  |  | $ | 93.1 |
Capitalizations |  | 40.1 |  |  | .9 |  |  | 41.0 |
Amortization expense |  | (10.9) |  |  | (.7) |  |  | (11.6) |
End of period |  | $ | 117.7 |  |  | $ | 4.8 |  |  | $ | 122.5 |
|  | Nine months ended
|  | September 30, 2023
|  | Fixed indexed annuities |  | Fixed interest annuities |  | Total
Beginning of period |  | $ | 76.0 |  |  | $ | 4.5 |  |  | $ | 80.5 |
Capitalizations |  | 16.3 |  |  | .6 |  |  | 16.9 |
Amortization expense |  | (8.0) |  |  | (.6) |  |  | (8.6) |
End of period |  | $ | 84.3 |  |  | $ | 4.5 |  |  | $ | 88.8 |

X
- References No definition available. + Details
Name: | us-gaap_DeferredChargesInsurersAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for cost related directly to successful acquisition of new and renewal of insurance contract. Includes, but is not limited to, deferred policy acquisition cost, deferred sale inducement cost, and present value of future profit of insurance contract acquired in business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 20 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479735/944-20-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479432/944-30-50-2A Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/944-30/tableOfContent + Details
Name: | us-gaap_InsuranceContractAcquisitionCostTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration